Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Wijsman, R.; Dankers, F.; Troost, E. G. C.; Hoffmann, A. L.; van der Heijden, E. H. F. M.; de Geus-Oei, L. F.; Bussink, J.
Abstract
Retrospective evaluation of 188 advanced stage non-small cell lung cancer patients treated with IMRT or VMAT revealed a limited increase of moderate to severe acute esophageal toxicity after VMAT. Acute pulmonary toxicity and severe late toxicity were low. Overall survival did not differ between the IMRT and VMAT groups.
Keywords: Non-small cell lung cancer; Intensity-modulated radiation therapy; Volumetric-modulated radiation therapy; Toxicity
-
Radiotherapy and Oncology 122(2017)2, 295-299
DOI: 10.1016/j.radonc.2016.11.015
Cited 29 times in Scopus
Permalink: https://www.hzdr.de/publications/Publ-25196
